Alicia Wallace,

Alicia Wallace is a senior writer for CNN Business covering the economy and topics such as cannabis. Based in the Bay Area, she specializes in writing economy feature articles that blend data and the human experience. Her coverage also includes articles on bigger-picture developments in the emerging cannabis industry. Before joining CNN, Wallace was a Knight-Bagehot Fellow at Columbia University in New York for the 2018-19 academic year. Prior to being selected for the business journalism and economics fellowship, Wallace covered the cannabis industry from a national lens for The Denver Post and its web vertical, The Cannabist. She has won gold (2013) and silver (2018) awards from the National Association Real Estate Editors association and numerous 1st, 2nd, and 3rd place awards from the Colorado Press Association, Colorado AP Editors and Reporters, and the Society of Professional Journalists. Wallace received a B.S. Journalism: News-Editorial with honors from the University of Colorado-Boulder.

100%

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

95%

Examples:

  • Attorney General Merrick Garland's signature signals the Biden administration's support for the decision.
  • Marijuana will be reclassified from a Schedule I drug to a Schedule III drug.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

Biden Administration Announces Plans to Reschedule Cannabis: From Schedule I to III

Biden Administration Announces Plans to Reschedule Cannabis: From Schedule I to III

Broke On: Friday, 03 May 2024 The Biden administration announced plans to loosen federal cannabis restrictions, moving marijuana from schedule I to schedule III on the Controlled Substances Act. This decision follows a review by the Department of Health and Human Services concluding that marijuana has medical benefits and potential for abuse. The change could support Biden among young voters, ease research, and grow the legal cannabis industry projected to reach $70 billion by 2030. However, public comment period and lawsuits are expected.